©2016 Bloomberg News O0GH0E6S9729 (Bloomberg) — Editas Medicine Inc., the drugmaker whose backers include Bill Gates and Google Ventures, filed to become the first publicly traded company to specialize in a new technology to edit flaws in genes. The company, which uses a gene-editing technique called Crispr, filed Monday for

published Sep 15th 2016, 5:25 pm, by Michelle Fay Cortez and Jennifer Jacobs (Bloomberg) — Republican presidential candidate Donald Trump is in “excellent physical health,” according to his longtime doctor Harold Bornstein, who on Thursday provided a range of details from the candidate’s laboratory reports for the first time. Trump’s